{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T16:47:54Z","timestamp":1781801274640,"version":"3.54.5"},"reference-count":62,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrinology and Metabolism Clinics of North America"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1016\/j.ecl.2019.08.009","type":"journal-article","created":{"date-parts":[[2019,9,19]],"date-time":"2019-09-19T17:06:26Z","timestamp":1568912786000},"page":"795-810","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"title":["Monogenic Forms of Hypertension"],"prefix":"10.1016","volume":"48","author":[{"given":"Filippo","family":"Ceccato","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franco","family":"Mantero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"28","key":"10.1016\/j.ecl.2019.08.009_bib1","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1093\/eurheartj\/eht151","article-title":"2013 ESH\/ESC guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)","volume":"34","author":"Mancia","year":"2013","journal-title":"Eur Heart J"},{"issue":"19","key":"10.1016\/j.ecl.2019.08.009_bib2","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1093\/eurheartj\/eht534","article-title":"Secondary arterial hypertension: when, who, and how to screen?","volume":"35","author":"Rimoldi","year":"2014","journal-title":"Eur Heart J"},{"issue":"3","key":"10.1016\/j.ecl.2019.08.009_bib3","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1210\/er.2018-00071","article-title":"Genetics of human primary hypertension: focus on hormonal mechanisms","volume":"40","author":"Manosroi","year":"2019","journal-title":"Endocr Rev"},{"issue":"25","key":"10.1016\/j.ecl.2019.08.009_bib4","doi-asserted-by":"crossref","first-page":"e510","DOI":"10.1161\/CIRCULATIONAHA.108.189141","article-title":"Resistant hypertension: diagnosis, evaluation, and treatment: a scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research","volume":"117","author":"Calhoun","year":"2008","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.ecl.2019.08.009_bib5","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s40292-018-0288-6","article-title":"Secondary arterial hypertension: from routine clinical practice to evidence in patients with adrenal tumor","volume":"25","author":"Grasso","year":"2018","journal-title":"High Blood Press Cardiovasc Prev"},{"key":"10.1016\/j.ecl.2019.08.009_bib6","doi-asserted-by":"crossref","first-page":"321","DOI":"10.3389\/fendo.2019.00321","article-title":"The pathophysiology and treatment of hypertension in patients with Cushing\u2019s syndrome","volume":"10","author":"Barbot","year":"2019","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"10.1016\/j.ecl.2019.08.009_bib7","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1210\/er.2010-0013","article-title":"The molecular biology, biochemistry, and physiology of human steroidogenesis and its disorders","volume":"32","author":"Miller","year":"2011","journal-title":"Endocr Rev"},{"issue":"3","key":"10.1016\/j.ecl.2019.08.009_bib8","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1055\/s-2002-35389","article-title":"Congenital adrenal hyperplasia: 11\u03b2-hydroxylase deficiency","volume":"20","author":"Peter","year":"2002","journal-title":"Semin Reprod Med"},{"issue":"3","key":"10.1016\/j.ecl.2019.08.009_bib9","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1210\/jc.2007-2417","article-title":"Approach to the adult with congenital adrenal hyperplasia due to 21-hydroxylase deficiency","volume":"93","author":"Merke","year":"2008","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.ecl.2019.08.009_bib10","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s12020-016-1189-x","article-title":"Clinical perspectives in congenital adrenal hyperplasia due to 11\u03b2-hydroxylase deficiency","volume":"55","author":"Bulsari","year":"2017","journal-title":"Endocrine"},{"issue":"1","key":"10.1016\/j.ecl.2019.08.009_bib11","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0021-9258(18)65119-1","article-title":"Plasma and urinary corticosteroids in the hypertensive form of congenital adrenal hyperplasia","volume":"223","author":"Bongiovanni","year":"1956","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.ecl.2019.08.009_bib12","doi-asserted-by":"crossref","DOI":"10.1007\/s12020-018-1691-4","article-title":"Insights on the phenotypic heterogeneity of 11\u03b2-hydroxylase deficiency: clinical and genetic studies in two novel families","author":"Valadares","year":"2018","journal-title":"Endocrine"},{"issue":"3","key":"10.1016\/j.ecl.2019.08.009_bib13","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.tem.2008.01.002","article-title":"Steroid 11\u03b2- hydroxylase deficiency congenital adrenal hyperplasia","volume":"19","author":"Nimkarn","year":"2008","journal-title":"Trends Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.ecl.2019.08.009_bib14","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1210\/jc.2007-0556","article-title":"Type of mutation and surgical procedure affect long-term quality of life for women with congenital adrenal hyperplasia","volume":"93","author":"Nordenskj\u00f6ld","year":"2008","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.ecl.2019.08.009_bib15","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1515\/jpem-2018-0298","article-title":"Typical characteristics of children with congenital adrenal hyperplasia due to 11\u03b2-hydroxylase deficiency: a single-centre experience and review of the literature","volume":"32","author":"Breil","year":"2019","journal-title":"J\u00a0Pediatr Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.ecl.2019.08.009_bib16","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1210\/jcem-56-2-222","article-title":"Clinical and biochemical variability of congenital adrenal hyperplasia due to 11 beta-hydroxylase deficiency. A study of 25 patients","volume":"56","author":"Zachmann","year":"1983","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.ecl.2019.08.009_bib17","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1159\/000179494","article-title":"Clinical variability of congenital adrenal hyperplasia due to 11 beta-hydroxylase deficiency","volume":"16","author":"R\u00f6sler","year":"1982","journal-title":"Horm Res"},{"issue":"10","key":"10.1016\/j.ecl.2019.08.009_bib18","doi-asserted-by":"crossref","first-page":"E1933","DOI":"10.1073\/pnas.1621082114","article-title":"Clinical, genetic, and structural basis of congenital adrenal hyperplasia due to 11\u03b2-hydroxylase deficiency","volume":"114","author":"Khattab","year":"2017","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"issue":"10","key":"10.1016\/j.ecl.2019.08.009_bib19","doi-asserted-by":"crossref","first-page":"4552","DOI":"10.1073\/pnas.90.10.4552","article-title":"Mutations in the CYP11B1 gene causing congenital adrenal hyperplasia and hypertension cluster in exons 6, 7, and 8","volume":"90","author":"Curnow","year":"1993","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"issue":"2","key":"10.1016\/j.ecl.2019.08.009_bib20","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1210\/jc.2015-1710","article-title":"Diagnosis and treatment of primary adrenal insufficiency: an endocrine society clinical practice guideline","volume":"101","author":"Bornstein","year":"2016","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2019.08.009_bib21","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jsbmb.2016.02.002","article-title":"Steroid 17-hydroxylase and 17,20-lyase deficiencies, genetic and pharmacologic","volume":"165","author":"Auchus","year":"2017","journal-title":"J\u00a0Steroid Biochem Mol Biol"},{"issue":"4781","key":"10.1016\/j.ecl.2019.08.009_bib22","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1126\/science.3535074","article-title":"Expression of bovine 17 alpha-hydroxylase cytochrome P-450 cDNA in nonsteroidogenic (COS 1) cells","volume":"234","author":"Zuber","year":"1986","journal-title":"Science"},{"issue":"12","key":"10.1016\/j.ecl.2019.08.009_bib23","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1210\/mend-5-12-2037","article-title":"Deletion within the CYP17 gene together with insertion of foreign DNA is the cause of combined complete 17 alpha-hydroxylase\/17,20-lyase deficiency in an Italian patient","volume":"5","author":"Biason","year":"1991","journal-title":"Mol Endocrinol"},{"issue":"10","key":"10.1016\/j.ecl.2019.08.009_bib24","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1007\/BF03346683","article-title":"Defects of steroidogenesis","volume":"33","author":"Biason-Lauber","year":"2010","journal-title":"J\u00a0Endocrinol Invest"},{"issue":"49","key":"10.1016\/j.ecl.2019.08.009_bib25","doi-asserted-by":"crossref","first-page":"48563","DOI":"10.1074\/jbc.M307586200","article-title":"CYP17 mutation E305G causes isolated 17,20-lyase deficiency by selectively altering substrate binding","volume":"278","author":"Sherbet","year":"2003","journal-title":"J\u00a0Biol Chem"},{"issue":"2","key":"10.1016\/j.ecl.2019.08.009_bib26","first-page":"38","article-title":"Arterial hypertension, hypokalemic alkalosis and male pseudohermaphroditism caused by 17 alpha-hydroxylase deficiency","volume":"101","author":"Mantero","year":"1971","journal-title":"Schweiz Med Wochenschr"},{"issue":"2","key":"10.1016\/j.ecl.2019.08.009_bib27","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0889-8529(18)30267-6","article-title":"17 alpha-hydroxylation deficiency","volume":"20","author":"Biglieri","year":"1991","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"1","key":"10.1016\/j.ecl.2019.08.009_bib28","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/0039-128X(94)00018-8","article-title":"Long-term treatment of mineralocorticoid excess syndromes","volume":"60","author":"Mantero","year":"1995","journal-title":"Steroids"},{"key":"10.1016\/j.ecl.2019.08.009_bib29","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jsbmb.2016.03.010","article-title":"Apparent mineralocorticoid excess","volume":"165","author":"Funder","year":"2017","journal-title":"J\u00a0Steroid Biochem Mol Biol"},{"key":"10.1016\/j.ecl.2019.08.009_bib30","first-page":"638","article-title":"Apparent mineralocorticoid excess","volume":"vol. 3","author":"Limumpornpetch","year":"2019"},{"issue":"5","key":"10.1016\/j.ecl.2019.08.009_bib31","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1210\/jcem-49-5-757","article-title":"A\u00a0syndrome of apparent mineralocorticoid excess associated with defects in the peripheral metabolism of cortisol","volume":"49","author":"Ulick","year":"1979","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.ecl.2019.08.009_bib32","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1210\/jcem-56-2-332","article-title":"Metabolic and blood pressure responses to hydrocortisone in the syndrome of apparent mineralocorticoid excess","volume":"56","author":"Oberfield","year":"1983","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"15","key":"10.1016\/j.ecl.2019.08.009_bib33","doi-asserted-by":"crossref","first-page":"10717","DOI":"10.1016\/S0021-9258(18)82044-0","article-title":"A\u00a0new isoform of 11 beta-hydroxysteroid dehydrogenase in aldosterone target cells","volume":"268","author":"Rusvai","year":"1993","journal-title":"J\u00a0Biol Chem"},{"issue":"7","key":"10.1016\/j.ecl.2019.08.009_bib34","first-page":"2263","article-title":"A\u00a0mutation in the HSD11B2 gene in a family with apparent mineralocorticoid excess","volume":"80","author":"Wilson","year":"1995","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"11","key":"10.1016\/j.ecl.2019.08.009_bib35","first-page":"3381","article-title":"The R337C mutation generates a high Km 11 beta-hydroxysteroid dehydrogenase type II enzyme in a family with apparent mineralocorticoid excess","volume":"80","author":"Obeyesekere","year":"1995","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.ecl.2019.08.009_bib36","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1152\/physrev.00020.2012","article-title":"11\u03b2-hydroxysteroid dehydrogenases: intracellular gate-keepers of tissue glucocorticoid action","volume":"93","author":"Chapman","year":"2013","journal-title":"Physiol Rev"},{"issue":"16","key":"10.1016\/j.ecl.2019.08.009_bib37","doi-asserted-by":"crossref","first-page":"9202","DOI":"10.1073\/pnas.1633591100","article-title":"Differential binding of NAD+ and NADH allows the transcriptional corepressor carboxyl-terminal binding protein to serve as a metabolic sensor","volume":"100","author":"Fjeld","year":"2003","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"issue":"4","key":"10.1016\/j.ecl.2019.08.009_bib38","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0039-128X(96)00012-8","article-title":"Apparent mineralocorticoid excess: type I and type II","volume":"61","author":"Mantero","year":"1996","journal-title":"Steroids"},{"issue":"3","key":"10.1016\/j.ecl.2019.08.009_bib39","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.tem.2005.02.011","article-title":"Monogenic low renin hypertension","volume":"16","author":"New","year":"2005","journal-title":"Trends Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.ecl.2019.08.009_bib40","doi-asserted-by":"crossref","DOI":"10.1111\/cen.13391","article-title":"Diagnostic accuracy of increased urinary cortisol\/cortisone ratio to differentiate ACTH-dependent Cushing\u2019s syndrome","volume":"87","author":"Ceccato","year":"2017","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ecl.2019.08.009_bib41","first-page":"199","article-title":"A\u00a0familial renal disorder simulating primary aldosteronism but with negligible aldosterone secretion","volume":"76","author":"Liddle","year":"1963","journal-title":"Trans Assoc Am Physicians"},{"issue":"6462","key":"10.1016\/j.ecl.2019.08.009_bib42","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/367463a0","article-title":"Amiloride-sensitive epithelial Na+ channel is made of three homologous subunits","volume":"367","author":"Canessa","year":"1994","journal-title":"Nature"},{"key":"10.1016\/j.ecl.2019.08.009_bib43","first-page":"652","article-title":"Liddle syndrome","volume":"vol. 3","author":"Rossi","year":"2019"},{"issue":"2","key":"10.1016\/j.ecl.2019.08.009_bib44","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1161\/HYPERTENSIONAHA.117.10491","article-title":"Three reportedly unrelated families with Liddle syndrome inherited from a common ancestor","volume":"71","author":"Pagani","year":"2018","journal-title":"Hypertension"},{"issue":"5","key":"10.1016\/j.ecl.2019.08.009_bib45","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1111\/jch.12949","article-title":"Liddle syndrome: clinical and genetic profiles","volume":"19","author":"Cui","year":"2017","journal-title":"J\u00a0Clin Hypertens"},{"issue":"4","key":"10.1016\/j.ecl.2019.08.009_bib46","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1111\/febs.13840","article-title":"ASIC and ENaC type sodium channels: conformational states and the structures of the ion selectivity filters","volume":"284","author":"Hanukoglu","year":"2017","journal-title":"FEBS J"},{"issue":"5","key":"10.1016\/j.ecl.2019.08.009_bib47","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1161\/HYPERTENSIONAHA.114.05092","article-title":"Molecular-based mechanisms of mendelian forms of salt-dependent hypertension","volume":"65","author":"Kurtz","year":"2015","journal-title":"Hypertension"},{"issue":"7286","key":"10.1016\/j.ecl.2019.08.009_bib48","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1038\/nature08783","article-title":"The cells and peripheral representation of sodium taste in mice","volume":"464","author":"Chandrashekar","year":"2010","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.ecl.2019.08.009_bib49","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1007\/s00467-014-2956-7","article-title":"Gordon syndrome: a continuing story","volume":"30","author":"O\u2019Shaughnessy","year":"2015","journal-title":"Pediatr Nephrol"},{"issue":"1","key":"10.1016\/j.ecl.2019.08.009_bib50","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1177\/003693308603100114","article-title":"The syndrome of hypertension and hyperkalaemia without renal failure: long term correction by thiazide diuretic","volume":"31","author":"Gordon","year":"1986","journal-title":"Scott Med J"},{"issue":"1","key":"10.1016\/j.ecl.2019.08.009_bib51","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1681\/ASN.2008121275","article-title":"WNK4 enhances the degradation of NCC through a sortilin-mediated lysosomal pathway","volume":"21","author":"Zhou","year":"2010","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"6","key":"10.1016\/j.ecl.2019.08.009_bib52","doi-asserted-by":"crossref","first-page":"e705","DOI":"10.1002\/mgg3.705","article-title":"A\u00a0familial case of pseudohypoaldosteronism type II (PHA2) with a novel mutation (D564N) in the acidic motif in WNK4","volume":"7","author":"Sakoh","year":"2019","journal-title":"Mol Genet Genomic Med"},{"issue":"10","key":"10.1016\/j.ecl.2019.08.009_bib53","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1139\/Y10-080","article-title":"The activity of the thiazide-sensitive Na\u00a0+ \u2013Cl \u2013 cotransporter is regulated by protein phosphatase PP4","volume":"88","author":"Glover","year":"2010","journal-title":"Can J Physiol Pharmacol"},{"issue":"4","key":"10.1016\/j.ecl.2019.08.009_bib54","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.ymgme.2010.12.010","article-title":"A\u00a0WNK4 gene variant relates to osteoporosis and not to hypertension in the Portuguese population","volume":"102","author":"Mendes","year":"2011","journal-title":"Mol Genet Metab"},{"issue":"5","key":"10.1016\/j.ecl.2019.08.009_bib55","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1073\/pnas.0510609103","article-title":"Antagonistic regulation of ROMK by long and kidney-specific WNK1 isoforms","volume":"103","author":"Lazrak","year":"2006","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"issue":"35","key":"10.1016\/j.ecl.2019.08.009_bib56","doi-asserted-by":"crossref","first-page":"14366","DOI":"10.1073\/pnas.1304230110","article-title":"WNK1-related familial hyperkalemic hypertension results from an increased expression of L-WNK1 specifically in the distal nephron","volume":"110","author":"Vidal-Petiot","year":"2013","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"issue":"10","key":"10.1016\/j.ecl.2019.08.009_bib57","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1042\/CS20130326","article-title":"Detection of mutations in KLHL3 and CUL3 in families with FHHt (familial hyperkalaemic hypertension or Gordon\u2019s syndrome)","volume":"126","author":"Glover","year":"2014","journal-title":"Clin Sci"},{"issue":"7","key":"10.1016\/j.ecl.2019.08.009_bib58","doi-asserted-by":"crossref","first-page":"3248","DOI":"10.1210\/jcem.87.7.8449","article-title":"Pseudohypoaldosteronism type II: marked sensitivity to thiazides, hypercalciuria, normomagnesemia, and low bone mineral density","volume":"87","author":"Mayan","year":"2002","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.ecl.2019.08.009_bib59","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.cmet.2012.08.011","article-title":"Cullin-3 regulates vascular smooth muscle function and arterial blood pressure via PPAR\u03b3 and RhoA\/Rho-kinase","volume":"16","author":"Pelham","year":"2012","journal-title":"Cell Metab"},{"issue":"5476","key":"10.1016\/j.ecl.2019.08.009_bib60","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1126\/science.289.5476.119","article-title":"Activating mineralocorticoid receptor mutation in hypertension exacerbated by pregnancy","volume":"289","author":"Geller","year":"2000","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.ecl.2019.08.009_bib61","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1210\/en.2002-220708","article-title":"The severe form of hypertension caused by the activating S810L mutation in the mineralocorticoid receptor is cortisone related","volume":"144","author":"Rafestin-Oblin","year":"2003","journal-title":"Endocrinology"},{"issue":"8","key":"10.1016\/j.ecl.2019.08.009_bib62","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/j.amjhyper.2005.02.020","article-title":"Analysis of the 11\u03b2-hydroxysteroid dehydrogenase type 2 gene (HSD11B2) in human essential hypertension","volume":"18","author":"Mariniello","year":"2005","journal-title":"Am J Hypertens"}],"container-title":["Endocrinology and Metabolism Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889852919300635?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889852919300635?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T09:44:42Z","timestamp":1760175882000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889852919300635"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":62,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["S0889852919300635"],"URL":"https:\/\/doi.org\/10.1016\/j.ecl.2019.08.009","relation":{},"ISSN":["0889-8529"],"issn-type":[{"value":"0889-8529","type":"print"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Monogenic Forms of Hypertension","name":"articletitle","label":"Article Title"},{"value":"Endocrinology and Metabolism Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ecl.2019.08.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}